Humira (adalimumab) is a prescription drug used for various conditions, including rheumatoid arthritis and plaque psoriasis. Mild side effects of the drug include injection site reactions, headache, ...
Medicare typically covers Humira through Part D when self-administered or Part B when administered by a doctor. As of 2025, Medicare beneficiaries won’t have to pay more than $2,000 ($2,100 in 2026) ...
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results